Search results
Regeneron Pharmaceuticals Inc (REGN) Q1 2024 Earnings Call Transcript Highlights: Key Financial ...
GuruFocus.com via Yahoo Finance· 6 days agoMarket Capitalization: Not directly mentioned, but financial health suggests a robust market cap. Gross Margin: Approximately 89% on net product sales. Sanofi Collaboration ...
Regeneron misses earnings, revenue expectations By Investing.com
Investing.com· 7 days agoThe biotechnology company announced an adjusted EPS of $9.55, which was below the consensus estimate...
Don't Overlook Cardiovascular Risk in Type 1 Diabetes
Medscape· 21 hours agoCardiovascular disease management is an often overlooked but critical aspect of care for people with...
Denali Therapeutics Q1 2024 Earnings: Misses Revenue Estimates Amid Strategic Shifts
GuruFocus.com via Yahoo Finance· 1 day agoThis decline was primarily due to reduced revenues from partnerships with Sanofi and Takeda. Despite these challenges, Denali has managed to reduce its total research and ...
Pfizer agrees to settle over 10,000 Zantac lawsuits
New Hampshire Union Leader· 12 hours agoPfizer has agreed to settle more than 10,000 lawsuits about cancer risks related to the now discontinued heartburn drug Zantac, Bloomberg News reported...
IPC Develops Consensus on Generalized Pustular Psoriasis
Medscape· 21 hours agoThe IPC's definition and diagnostic criteria for GPP minimized the complexity of clinical...
Small Business - Austin Daily Herald | Austin Daily Herald
Austin Daily Herald· 7 days agoFirst quarter 2024 revenues decreased 1% to $3.15 billion versus first quarter 2023; excluding RonapreveTM(a)(b), revenues increased 7%First quarter 2024 Dupixent® global net sales (recorded ...
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 6 days agoRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q1 2024 Earnings Call Transcript May 2, 2024 Regeneron...
Regeneron Pharmaceuticals Inc (REGN) Q1 2024 Earnings: Challenges and Opportunities Amidst ...
GuruFocus.com via Yahoo Finance· 7 days agoAmong its key products are Eylea, approved for various eye diseases, and Dupixent, used in treating...
Shanghai to Build New Resort Near Shanghai Disneyland, Starts Inviting Global Investment
Digital Journal· 1 day agoAnnounces Quarterly Dividend...